GRO Biosciences, a small but ambitious biotech startup attempting to create novel protein drugs from genetically modified ...

Curevo Vaccine raises $110M Series B for shingles vaccine trial extension, adds Moncef Slaoui as board chair and Moderna's ...

AstraZeneca is fine-tuning plans for a Phase 3 study for its B7-H4-targeting ADC after the drug produced encouraging response ...

Taiho Pharmaceutical to acquire Swiss biotech Araris for $400M upfront, gaining three antibody-drug conjugates. Deal follows ...

Avidity Biosciences shared Monday that its RNA drug for people with certain mutations of Duchenne muscular dystrophy ...

AstraZeneca to acquire EsoBiotec for $425M upfront, with $575M in potential milestones. Deal centers on platform technology ...

Latigo Biotherapeutics raises $150M Series B to advance Nav1.8 inhibitors for pain, competing with Vertex's Journavx.

Maxion Therapeutics has secured $72 million in an oversubscribed Series A raise, with Eli Lilly pitching in, to advance its ...

HHS Secretary Robert F. Kennedy Jr. and his staff last Wednesday hosted a regenerative medicine roundtable primarily to ...

The US Court of Appeals for the Federal Circuit on Friday ruled against Regeneron in a closely-watched patent infringement ...

Fauna Bio, a biotech that mines data on disease resistance from squirrels and other animals to create new drugs, is looking ...

Mehmet Oz has committed to defending Medicare drug price negotiations in court if he is confirmed to lead CMS.